Spring Top 200 Final Flashcards
atorvastatin
Lipitor, Caduet (combo product).
HMG-CoA Reductase Inhibitor.
Dyslipidemia.
BBW: N/A
omega-3-polyunsaturated fatty acids
Lovaza.
Antilipemic Agent, Omega-3 Fatty Acids.
Hypertriglyceridemia.
BBW: N/A
furosemide
Lasix.
Loop Diuretic.
Edema in HF, HTN, acute pulmonary edema
BBW: Fluid & Electrolyte Depletion
hydrochlorothiazide
Microzide.
Thiazide Diuretic.
HTN & edema
BBW: N/A
clonidine
Catapres, Catapres-TTS.
Alpha2 Agonist.
HTN
BBW: The 500 mcg/mL strength product should be diluted prior to use in an appropriate solution (injectable form).
metoprolol succinate
Toprol XL. BB.
Angina pectoris, HTN, or hemodynamically-stable acute MI.
BBW: Avoid abrupt cessation in ischemic heart disease
carvedilol
Coreg, Coreg CR.
BB with Alpha1-Blocking Activity
Indication: Mild-to-severe heart failure
BBW: N/A
amlodipine
Norvasc, Caduet (combo product), Lotrel (combo product).
CCB (Dihydropyridine).
HTN, angina.
BBW: N/A
diltiazem
Cardizem CD, Cardizem SR, Cartia XT.
CCB (Nondihydropyridine).
HTN, angina.
BBW: N/A
lisinopril
Zestril, Prinivil.
ACEI.
HTN, HF, MI.
BBW: fetal toxicity
digoxin
Digitek, Lanolin.
Antiarrhythmic, Cardiac Glycoside.
Afib & HF.
BBW: N/A
isosorbide dinitrate
Isordil.
Antianginal agent.
Angina prevention.
BBW: N/A
warfarin
Coumadin.
Vit K Antagonist.
Ppx and tx of thromboembolic disorders arising from afib/cardiac valve replacement; reduce risk of systemic embolism.
BBW: Bleeding risk
clopidogrel
Plavix.
Anti platelet Agent.
Unstable angina; NSTEMI; STEMI; recent MI/stroke; established PAD.
BBW: Increased levels in poor metabolizers (CYP 2C19)
enoxaparin
Lovenox.
LMWH.
Ppx and tx of DVT, unstable angina, NSTEMI, & STEMI.
BBW: Spinal/epidural hematomas
dabigatran
Pradaxa.
Thrombin Inhibitor.
Ppx of stroke & systemic embolism in patients with nonvalvular afib.
BBW: Discontinuing early inc risk of thrombotic event; spinal/epidural hematoma
rivaroxaban
Xarelto.
Factor Xa inhibitor.
Ppx of DVT in pts undergoing hip/knee replacement; prevention of stroke & systemic embolism in patients with nonvalvular afib; tx of acute PE & DVT without PE.
BBW: Discontinuing early inc risk of thrombotic event; spinal/epidural hematomas
amiodarone
Cordarone, Pacerone.
Antiarrhythmic Agent, Class III.
Ventricular arrythmias (vtach, vfib).
BBW: only for life-threatening arrhythmias, fatal toxicities, patients at high risk arrhythmic death
dofetilide
Tikosyn
Antiarrhythmic Agent, Class III
Mx of NSR in pts with chronic afib/a-flutter of longer than 1-week duration who have been converted to NSR; conversion of afib & a-flutter to NSR
BBW: should be placed for a minimum of 3 days in a facility that can provide calc of CrCl, continuous EKG monitoring, & cardiac resuscitation
alteplase
Activase.
Tissue plasminogen activator; fibrinolytic.
PE, STEMI, acute ischemic stroke.
BBW: N/A